2023 Life Sciences Digital Pathology Adoption Survey Report
What You Should Know:
Nearly three-fourths of life sciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®. Over half of these organizations (53%) still…
Continue Reading